US Patent Issued to PROPAGENIX on Sept. 29 for "Ex vivo proliferation of epithelial cells" (Maryland Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,425, issued on Sept. 29, was assigned to PROPAGENIX INC..

"Ex vivo proliferation of epithelial cells" was invented by Chengkang Zhang (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The technology relates in part to methods and compositions for ex vivo proliferation and expansion of epithelial cells."

The patent was filed on May 8, 2023, under Application No. 18/144,733.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12747425&OS=12747425&RS=12747425

Disclaimer: C...